Page 15 - Pharmaceutical
Make plant inspection reports public, Indian Pharmaceutical Alliance tells government
Recommendation comes in the backdrop of inspections at 76 manufacturing units carried out by CDSCO and state drug regulators
 "Make plant inspection reports public, Indian Pharmaceutical Alliance tells government")
Bliss GVS Pharma bags $ 111 million contract in Kenya
The company operates an innovative public-private engagement model to address unmet healthcare requirements in Kenya through its chain of clinics and partner service providers
 "Bliss GVS Pharma bags $ 111 million contract in Kenya")
Clariant aims to start Cuddalore healthcare packaging facility in 2017
The company also plans to expand production by adding high-capacity multi-lane production line for its versatile Continu-Strip desiccant packets
 "Clariant aims to start Cuddalore healthcare packaging facility in 2017")
Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D
Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the industry
 "Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D")
Roche launches global initiative for cancer treatment research
The company will invest up to Swiss Francs 100 million (about $ 100 million) to support basic and clinical research collaborations within the imCORE Network
 "Roche launches global initiative for cancer treatment research")
Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US
The application, which is believed to be the first for a proposed biosimilar trastuzumab in the US, marks first US regulatory submission through the Mylan-Biocon collaboration
 "Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US")
Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn
The medical device maker, who has pleaded guilty to misbranding its embolic device LC Bead, will pay the amount to resolve criminal liability and False Claims Act allegations
 "Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn")
Merck invests Euro 250 mn to expand pharma business' production in China
The investment will support Merck's expansion in China, which is expected to become the world's second-largest pharmaceutical market by 2018
 "Merck invests Euro 250 mn to expand pharma business' production in China")
European Medicines Agency accepts Mylan-Biocon's insulin glargine application
Glargine is one of the three insulin analogs being co-developed for the global marketplace by Mylan and Biocon - who are partners for a broad portfolio of biosimilars and insulin analogs
 "European Medicines Agency accepts Mylan-Biocon's insulin glargine application")
Sun Pharma buys US-based Ocular Technologies for $ 40 million
The acquisition of Ocular Technologies, which is developing Seciera for the treatment of Dry Eye Disease, will enhance Sun Pharma's specialty ophthalmic pipeline
 "Sun Pharma buys US-based Ocular Technologies for $ 40 million")
Glenmark receives US FDA's nod for antifungal cream
The company has received final approval for nystatin and triamcinolone acetonide cream (100,000 units per gm and 1 mg per gm)
IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals
The CGMP facility will help in extraction, formulation and packaging of medicinal plant based phyto-pharmaceutical drugs
 "IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals")
Large scale imports of APIs from China worries Indian pharma industry
Overwhelming dependence on China for crucial active pharmaceutical ingredients (APIs) and intermediates has emerged as a main worrying area, as per the Assocham-RNCOS study
 "Large scale imports of APIs from China worries Indian pharma industry")
Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector
The company has agreed for the payment to resolve questions that have been raised about the classification of EpiPen auto-injector for purposes of the Medicaid Drug Rebate Program
 "Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector")
Dr Reddy's Labs forays into Colombia
The company will launch its portfolio of high quality and affordable medicines for cancer patients in the Colombian pharmaceutical market
 "Dr Reddy's Labs forays into Colombia")
Indian biosimilars market to reach $ 40 bn by 2030: Study
With a new regulatory policy and increased affordability offered by biosimilars, the domestic market is expected to grow at an accelerated pace, says a Assocham-Sathguru Management report
 "Indian biosimilars market to reach $ 40 bn by 2030: Study")
Lupin to use MonoSol technology for developing paediatric products
The Mumbai-headquartered will develop multiple paediatric products utilising the US-based MonoSol Rx's proprietary PharmFilm drug delivery technology
 "Lupin to use MonoSol technology for developing paediatric products")
Zydus to market immunosuppressant drug of Switzerland's Neovii in India
The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplant
 "Zydus to market immunosuppressant drug of Switzerland's Neovii in India")
Jubilant's lyophilised kit for radiopharmaceuticals receives Australian approval
The company has received TGA's nod for lyophilised kit for the preparation of Technetium 99m Macro-Aggregated Albumin (MAA) injection
Emergent BioSolutions bags $1.6 bn contract for anthrax vaccine in US
The company was awarded the contract by the Biomedical Advanced Research and Development Authority (BARDA) for advanced development & delivery of NuThrax vaccine